286
Participants
Start Date
July 31, 2016
Primary Completion Date
August 13, 2019
Study Completion Date
August 13, 2019
Tdap
Commercially available, U.S. and Guatemala licensed, 0.5mL intramuscular injection combination tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine
Td
The tetanus toxoid and reduced diphtheria toxoid vaccine (Td) used for this study will be the same preparation used by the National Immunization Program of Guatemala
Universidad del Valle de Guatemala, Guatemala City
Universidad del Valle, Guatemala
OTHER
Emory University
OTHER